论文部分内容阅读
目的:观察氨溴特罗治疗毛细支气管炎的临床疗效。方法:76例毛细支气管炎患儿随机为治疗组和对照组各38例。两组均采用利巴韦林抗病毒,布地奈德雾化吸入,以及拍背吸痰、吸氧、补液等综合方法治疗,治疗组在此基础上加用氨溴特罗口服液。比较两组疗效。结果:治疗组喘息、咳嗽等症状以及哮鸣音、湿啰音持续时间,住院天数等指标均优于对照组(P<0.01),治愈率高于对照组(P<0.01)。两组总有效率差异无统计学意义。结论:氨溴特罗治疗毛细支气管炎安全有效,可以减少静脉糖皮质激素的应用。
Objective: To observe the clinical efficacy of ambroxol in the treatment of bronchiolitis. Methods: 76 children with bronchiolitis were randomized to treatment group and control group, 38 cases each. Both groups were treated with ribavirin antiviral, budesonide inhalation, as well as sucked back sputum suction, oxygen, rehydration and other comprehensive treatment, the treatment group on this basis with the use of ambroxol oral solution. Compare the two groups curative effect. Results: The symptoms such as wheezing, coughing, duration of wheezing, duration of wet rales and days of hospital stay in the treatment group were better than those in the control group (P <0.01). The cure rate was higher in the treatment group than in the control group (P <0.01). There was no significant difference between the two groups in total effective rate. Conclusion: Ambroxol treatment of bronchiolitis is safe and effective, can reduce the application of intravenous glucocorticoid.